Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DTC - Differentiated Thyroid Cancer”

165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 165 results

Not applicableStudy completedNCT03986437
What this trial is testing

A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.

Who this might be right for
Differentiated Thyroid Cancer
Institut Claudius Regaud 29
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Not applicableActive Not RecruitingNCT04948437
What this trial is testing

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Who this might be right for
Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer
National Taiwan University Hospital 103
Not applicableStudy completedNCT07115810
What this trial is testing

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

Who this might be right for
Differentiated Thyroid Cancer
King Faisal Specialist Hospital & Research Center 178
Testing effectiveness (Phase 2)Study completedNCT04137185
What this trial is testing

Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients

Who this might be right for
Differentiated Thyroid Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 64
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Early research (Phase 1)Study completedNCT01438554
What this trial is testing

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

Who this might be right for
Solid TumorsThyroid CancerSoft-tissue Sarcoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453225
What this trial is testing

Empirical Radioactive Iodine Therapy in DTC

Who this might be right for
Differentiated Thyroid Cancer
Assiut University 100
Not applicableStudy completedNCT02304757
What this trial is testing

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Who this might be right for
Differentiated Thyroid CancerOsteoporosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142
Testing effectiveness (Phase 2)Active Not RecruitingNCT04560127
What this trial is testing

Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioactive Iodine-refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Not applicableActive Not RecruitingNCT03416686
What this trial is testing

Radiofrequency in Differentiated Thyroid Cancer Metastatic Lymph Node: Prospective Study of Safety and Efficacy

Who this might be right for
Differentiated Thyroid Cancer
Assistance Publique - Hôpitaux de Paris 14
Testing effectiveness (Phase 2)Study completedNCT01723202
What this trial is testing

Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer

Who this might be right for
Follicular Thyroid CancerInsular Thyroid CancerPapillary Thyroid Cancer+1 more
Bhavana Konda 53
Testing effectiveness (Phase 2)Study completedNCT02432274
What this trial is testing

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Who this might be right for
TumorsSolid Malignant TumorsOsteosarcoma+1 more
Eisai Limited 117
Not applicableUnknownNCT06062563
What this trial is testing

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Who this might be right for
Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
Peking Union Medical College Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00668811
What this trial is testing

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerDifferentiated Thyroid Cancer
Medstar Health Research Institute 23
Testing effectiveness (Phase 2)Study completedNCT03244956
What this trial is testing

Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer

Who this might be right for
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
Gustave Roussy, Cancer Campus, Grand Paris 40
Testing effectiveness (Phase 2)Study completedNCT00279721
What this trial is testing

Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.

Who this might be right for
Thyroid Neoplasms
Alberta Health services 40
Early research (Phase 1)Looking for participantsNCT05538130
What this trial is testing

Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Who this might be right for
MelanomaGliomaThyroid Cancer+10 more
Pfizer 124
Not applicableApproved For MarketingNCT02211222
What this trial is testing

An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Eisai Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06848920
What this trial is testing

Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma

Who this might be right for
Differentiated Thyroid Carcinoma (DTC)Neoadjuvant Therapy
Zhejiang University 20
Load More Results